An endocrinologist specializing in thyroid cancer and creator of the Hemoglobin A1c test for diabetes reflects on his career, offering advice for aspiring researchers.

The U-M-led development and validation of a staging system for non-metastatic prostate cancer could help doctors and patients assess treatment options, as well as improve clinical trials.

A U-M Rogel Cancer study provides an updated, more comprehensive look at trends for this rare, aggressive form of breast cancer over the last four decades.

The new approach could help doctors to separate aggressive stage 0 breast cancer from non-aggressive forms, sparing some women unnecessary mastectomies.

Though they often receive little fanfare, postdocs are critical to the success of the Rogel Cancer Center’s research programs.

A first-ever report describes how overall gains against cancer are not benefiting some racial and ethnic groups – and how COVID-19 may be making it worse.